These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 19060284

  • 1. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
    Kim JH, Kim JH, Yu YS, Kim DH, Kim CJ, Kim KW.
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
    [Abstract] [Full Text] [Related]

  • 2. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
    Wang Y, An R, Dong X, Pan S, Duan G, Sun X.
    Urol Int; 2009 Apr; 82(2):214-21. PubMed ID: 19322013
    [Abstract] [Full Text] [Related]

  • 3. Novel human neutrophil agonistic properties of arsenic trioxide: involvement of p38 mitogen-activated protein kinase and/or c-jun NH2-terminal MAPK but not extracellular signal-regulated kinases-1/2.
    Binet F, Girard D.
    J Leukoc Biol; 2008 Dec; 84(6):1613-22. PubMed ID: 18728151
    [Abstract] [Full Text] [Related]

  • 4. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W, Adachi M, Zhang R, Zhou J, Zhu D.
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [Abstract] [Full Text] [Related]

  • 5. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
    Sánchez Y, Simón GP, Calviño E, de Blas E, Aller P.
    J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
    [Abstract] [Full Text] [Related]

  • 6. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A.
    Cancer Res; 2001 Jul 15; 61(14):5432-40. PubMed ID: 11454688
    [Abstract] [Full Text] [Related]

  • 7. Effect of arsenic trioxide on uveal melanoma cell proliferation in vitro.
    Wang C, Li B, Zhang H, Shi G, Li W, Jonas JB.
    Ophthalmic Res; 2007 Jul 15; 39(6):302-7. PubMed ID: 17957129
    [Abstract] [Full Text] [Related]

  • 8. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
    Liu Y, Hock JM, Sullivan C, Fang G, Cox AJ, Davis KT, Davis BH, Li X.
    J Cell Biochem; 2010 Dec 15; 111(6):1546-55. PubMed ID: 20862710
    [Abstract] [Full Text] [Related]

  • 9. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH, Moon HJ, You BR, Kim SZ, Kim SH, Park WH.
    Anticancer Res; 2009 Oct 15; 29(10):3837-44. PubMed ID: 19846917
    [Abstract] [Full Text] [Related]

  • 10. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH.
    Han YH, Kim SZ, Kim SH, Park WH.
    Cancer Lett; 2008 Oct 18; 270(1):40-55. PubMed ID: 18539383
    [Abstract] [Full Text] [Related]

  • 11. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
    Zhao XS, Song PL, Sun B, Jiang HC, Liu TF.
    Hepatobiliary Pancreat Dis Int; 2009 Oct 18; 8(5):510-7. PubMed ID: 19822495
    [Abstract] [Full Text] [Related]

  • 12. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y.
    Biochem Biophys Res Commun; 2002 Mar 08; 291(4):861-7. PubMed ID: 11866444
    [Abstract] [Full Text] [Related]

  • 13. Antitumor effects of arsenic trioxide in transformed human thyroid cells.
    Fröhlich E, Czarnocka B, Brossart P, Wahl R.
    Thyroid; 2008 Nov 08; 18(11):1183-93. PubMed ID: 19014326
    [Abstract] [Full Text] [Related]

  • 14. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases.
    Sánchez Y, Calle C, de Blas E, Aller P.
    Chem Biol Interact; 2009 Nov 10; 182(1):37-44. PubMed ID: 19720055
    [Abstract] [Full Text] [Related]

  • 15. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
    Lam HK, Li K, Chik KW, Yang M, Liu VC, Li CK, Fok TF, Ng PC, Shing MM, Chuen CK, Yuen PM.
    Int J Oncol; 2005 Aug 10; 27(2):537-45. PubMed ID: 16010437
    [Abstract] [Full Text] [Related]

  • 16. Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis.
    Han YH, Kim SZ, Kim SH, Park WH.
    Am J Physiol Renal Physiol; 2007 Aug 10; 293(2):F511-20. PubMed ID: 17507598
    [Abstract] [Full Text] [Related]

  • 17. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
    Jin HO, Yoon SI, Seo SK, Lee HC, Woo SH, Yoo DH, Lee SJ, Choe TB, An S, Kwon TJ, Kim JI, Park MJ, Hong SI, Park IC, Rhee CH.
    Biochem Pharmacol; 2006 Nov 15; 72(10):1228-36. PubMed ID: 16950207
    [Abstract] [Full Text] [Related]

  • 18. ASK1 is activated by arsenic trioxide in leukemic cells through accumulation of reactive oxygen species and may play a negative role in induction of apoptosis.
    Yan W, Arai A, Aoki M, Ichijo H, Miura O.
    Biochem Biophys Res Commun; 2007 Apr 20; 355(4):1038-44. PubMed ID: 17331470
    [Abstract] [Full Text] [Related]

  • 19. Tumor growth inhibition of metastatic nasopharyngeal carcinoma cell lines by low dose of arsenic trioxide via alteration of cell cycle progression and induction of apoptosis.
    Yeh KY, Chang JW, Li YY, Wang CH, Wang HM.
    Head Neck; 2011 May 20; 33(5):734-42. PubMed ID: 20737493
    [Abstract] [Full Text] [Related]

  • 20. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
    Chien CW, Yao JH, Chang SY, Lee PC, Lee TC.
    Toxicol Appl Pharmacol; 2011 Nov 15; 257(1):59-66. PubMed ID: 21889949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.